Practice
10-Minute Consultation
Herpes zoster ophthalmicus
Fook Chang Lam, specialist registrar in ophthalmology1, Allison Law, general practitioner2, William
Wykes, consultant ophthalmologist1
1
Department of Ophthalmology, Southern General Hospital, Glasgow G51 4TF, 2 Southbank Surgery, 17-
most patients are aged over 50 years. Other causes include stress, fatigue, and a weakening of the
immune system from other illnesses or from medical treatment (such as chemotherapy or
immunosuppression).
When the eruption involves the area around the eye (the ophthalmic or first division of the trigeminal
nerve), this is called herpes zoster ophthalmicus, irrespective of whether the actual eye itself is involved.
Ophthalmic herpes zoster accounts for 10-25% of all cases of shingles.
Have I got the right diagnosis?
The main differential diagnosis is herpes simplex infection. In herpes simplex the patients are usually
young, and the rash will not follow a dermatome, nor will it obey the midline. In herpes zoster
ophthalmicus it is not unusual for the oedema to track to the other side of the face, but the rash remains
dermatomal in distribution.
Can I predict who will get eye problems?
The appearance of the rash on the tip, the side, or the root of the nose indicates the involvement of the
nasociliary nerve (Hutchinsons sign) and a higher risk of ocular involvement (80%). Age, sex, and severity
of skin rash are not good predictors.
What are the possible ocular complications?
These usually develop from the second week after the onset of the rash. Post-herpetic neuralgia is by far
the commonest complication. Age is a potent risk factor. Antiviral drugs reduce the risk by 50%, but 20% of
affected patients aged over 50 will continue to report pain six months on despite initial antiviral treatment.
Less common complications are:
Useful reading
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect
Dis 2007;44(suppl 1):S1-26
Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6, doi:10.1056/NEJMcp013211
Wareham DW, Breuer J. Herpes zoster (Clinical review). BMJ 2007;334:1211-15, doi:10.1136/bmj.39206.571042.AE
Systemic antiviral treatment shortens the healing process of acute herpes zoster and reduces pain and other acute and
chronic complications when given within 72 hours after onset of the rash.
Older patients shed the virus for longer and have a higher risk of complications and could still benefit from antivirals after this
period, especially if they still have new vesicles forming.
Antivirals should be considered in all patients with herpes zoster ophthalmicus, even if they are presenting after 72 hours.
Aciclovir, valaciclovir, and famciclovir are accepted in the United Kingdom as first line treatments. They are similar in tolerability
and safety, but aciclovir is usually the drug of choice on grounds of cost effectiveness. Some doctors prefer valaciclovir and
famciclovir because of the superior pharmacokinetics and more convenient dosing regimens.
Supplementary treatment with corticosteroids may shorten the degree and duration of acute zoster pain but has no effect on
the development of post-herpetic neuralgia.
This is part of a series of occasional articles on common problems in primary care. The BMJ welcomes
contributions from GPs
Competing interests: None declared.
Provenance and peer review: Not commissioned; externally peer reviewed.
(Accepted 19 March 2008)
CiteULike
Complore
Connotea
StumbleUpon
Technorati
Del.icio.us
What's this?
Relevant Articles
Dont forget HIV
Kathir Yoganathan
BMJ 2009 339: b3621. [Extract] [Full Text]
Digg
Herpes zoster
David W Wareham and Judith Breuer
BMJ 2007 334: 1211-1215. [Extract] [Full Text] [PDF]